NCBiotech News

We work hard to bring you the stories about the life science community in North Carolina. Every once in a while, we add a little news of our own. Read some of those stories below, or check out some of our perspectives on our staff blog.

Knee exam
Bioventus, a global orthobiologics company headquartered in Durham, will acquire Misonix, a New York-based developer of ultrasonic surgical devices, in a cash-and-stock transaction valued at about $518 million.
NCBiotech
The North Carolina Biotechnology Center awarded 21 grants and loans totaling more than $1.9 million to universities and bioscience companies and other entities in the fourth quarter of its fiscal year.
Seqirus vaccine manufacturing in Holly Springs
Seqirus, the global vaccine maker with a mega factory in Holly Springs, has just begun to ship its portfolio of seasonal flu vaccines to healthcare providers across the United States. It is prepared to supply approximately 60 million doses to meet demand for the 2021-2022 flu season.
Bluebird bio
Bluebird bio, a Massachusetts-based gene and cell therapy company with operations in North Carolina, will sell its Durham biomanufacturing plant to National Resilience for $110 million as part of a strategic alliance between the two companies.
NIEHS logo
NIEHS’s 24th annual Biomedical Career Symposium will be held virtually on Thursday and Friday, August 26 and 27.
Bionetwork Virtual Career Fair logo
If you're interested in a life sciences career, mark your calendar for Wednesday, August 4 when BioNetwork hosts its fifth virtual career fair in partnership with biopharmaceutical and life sciences companies from across the state.
Raleigh skyline. -- Shutterstock
Raleigh emerged as the No. 5 metro area in the latest Wall Street Journal/Realtor.com Emerging Housing Markets Index, while Burlington hit #19 and Durham-Chapel Hill ranked #22 among the nation's top 300 markets.
Merakris Opticyte Disk is application
RTP regenerative health company Merakris Therapeutics is providing a new eye-care product to eye surgeons and their patients in the Carolinas and Texas, thanks to a partnership with Winston-Salem nonprofit Miracles in Sight.
North Carolina has one of the largest biopharma manufacturing industries in the nation, and a well-coordinated workforce development network is providing the right stuff to keep it growing.
Rukiyah Van Dross-Anderson, Ph.D.
A compound developed by Rukiyah Van Dross-Anderson, Ph.D., an associate professor at ECU, with grant support from NCBiotech, could lead to more-effective skin cancer treatments.
regenerated tissue
Two teams of researchers from the Wake Forest Institute for Regenerative Medicine have won top awards and a combined $400,000 in a five-year NASA competition, beating nine other teams and creating viable vessel tissue from human cells.
Kriya leadership
Kriya Therapeutics is poised to revolutionize gene therapies for highly serious diseases like diabetes and severe obesity after landing a whopping $100 million in capital.
Osteoamp demo
Bioventus logo
.

Durham-based Bioventus, a global med tech company which went public earlier this year, is releasing a new product to its lineup that uses human tissue to improve bone fusions.

Plug greenhouse
A new training program at Durham Tech will prepare students for good-paying entry-level jobs in North Carolina’s growing agricultural biotechnology industry beginning this fall
Xilis cofounders
Durham-based Xilis has raised $70 million in Series A financing to advance its precision oncology platform.